Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.08.2019 | Case report

Dabigatran etexilate

Intracranial haemorrhage and haemorrhagic infarction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

An 81-year-old woman developed intracranial haemorrhage and haemorrhagic infarction during treatment with dabigatran etexilate for atrial fibrillation. …
Literatur
Zurück zum Zitat Bellavita G, et al. Reversal agent idaracizumab for the management of intracerebral haemorrhage in dabigatran treated patient: A case report. European Stroke Journal 4 (Suppl. 1): 197 abstr. AS35-105, 2019. Available from: URL: http://doi.org/10.1177/2396987319845581 [abstract] - Italy Bellavita G, et al. Reversal agent idaracizumab for the management of intracerebral haemorrhage in dabigatran treated patient: A case report. European Stroke Journal 4 (Suppl. 1): 197 abstr. AS35-105, 2019. Available from: URL: http://​doi.​org/​10.​1177/​2396987319845581​ [abstract] - Italy
Metadaten
Titel
Dabigatran etexilate
Intracranial haemorrhage and haemorrhagic infarction: case report
Publikationsdatum
01.08.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-65891-2

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Gabapentin

Case report

Ustekinumab